Medicinal Oxygen/Pantogas

Oxygen, the active ingredient in Medicinal Oxygen/Pantogas, is a respiratory gas presented as a medical gas for inhalation use. It is employed to support patients with hypoxemia, respiratory distress, carbon‑monoxide poisoning and postoperative oxygen supplementation, providing essential molecular oxygen for tissue oxygenation by increasing the partial pressure of oxygen in the alveoli and facilitating diffusion into the bloodstream.

GNH USA supplies Medicinal Oxygen/Pantogas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Medicinal Oxygen/Pantogas is used in respiratory therapy to correct low blood oxygen levels. - Hypoxemia: restores adequate arterial oxygen saturation in patients with reduced blood oxygen. - Respiratory distress: alleviates breathing difficulty by increasing available oxygen for gas exchange. - Carbon‑monoxide poisoning: displaces carbon monoxide from hemoglobin and accelerates its elimination. - Post‑operative supplementation: supports recovery by maintaining optimal oxygen levels after surgery.

Oxygen therapy may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Dry nasal passages: irritation of the nasal mucosa from dry gas flow. - Mild cough: reflex cough due to airway irritation. - Headache: transient headache related to changes in oxygen tension. - Fatigue: feeling of tiredness during or after therapy.

Serious or Rare Side Effects: - Pulmonary oxygen toxicity: inflammation or damage to lung tissue with prolonged high concentrations. - Seizures: central nervous system excitation in cases of hyperoxia. - Fire hazard: increased risk of combustion in the presence of flammable materials. - Retinopathy of prematurity: ocular damage in preterm infants exposed to high oxygen levels.

When using Medicinal Oxygen/Pantogas, clinicians should observe the following precautions to ensure safety and efficacy. - Assess patient oxygen saturation before use: confirm need for supplemental oxygen. - Avoid use in untreated pneumothorax: risk of tension pneumothorax. - Monitor for signs of hyperoxia: watch for dizziness, visual changes, or respiratory irritation. - Use flame‑resistant equipment: minimize fire risk in oxygen‑rich environments. - Do not exceed prescribed flow rate: follow clinician‑determined settings. - Store at ambient temperature: keep cylinder in a well‑ventilated, dry area, protected from heat and direct sunlight.

Oxygen can interact with certain agents or conditions, requiring attention to avoid complications.

Major Interactions (Avoid): - Flammable anesthetic gases (e.g., nitrous oxide, halothane): increased fire hazard. - Smoking or open flames in treatment area: risk of combustion.

Moderate Interactions (Monitor Closely): - High‑dose antioxidant therapy (e.g., vitamin C): may alter oxidative balance. - Certain chemotherapy agents (e.g., bleomycin): potential for enhanced pulmonary toxicity. - Carbon dioxide retention disorders (e.g., COPD): monitor for hypercapnia.